| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.1 | 0.5 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |